MAPT and early-onset autosomal dominant Alzheimer disease: Research is showing that the rapid escalation in tau protein and decline in amyloid indicates when individuals enter the more aggressive phase of Alzheimer's disease [44] and provides a potential opportunity for medical treatments to have the most benefit.